[CAS NO. 269055-15-4]  Etravirine (TMC125)

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [269055-15-4]

Distributor
Catalog
SLK-S3080
Brand
Selleck
CAS
269055-15-4

DESCRIPTION [269055-15-4]

Overview

MDLMFCD09837879
Molecular Weight435.28
Molecular FormulaC20H15BrN6O
SMILESO(C1=NC(NC2=CC=C(C#N)C=C2)=NC(N)=C1Br)C3=C(C)C=C(C#N)C=C3C

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2974 mL11.4869 mL22.9737 mL
5 mM0.4595 mL2.2974 mL4.5947 mL
10 mM0.2297 mL1.1487 mL2.2974 mL
50 mM0.0459 mL0.2297 mL0.4595 mL

Description

Etravirine (TMC125, R-165335) is a non-nucleoside reverse transcriptase inhibitor () used for the treatment of HIV.

Targets

Reverse transcriptase [1]

In vitro

Etravirine (TMC125), is highly active against wild-type HIV-1 with EC50 of 1.4 nM to 4.8 nM and shows some activity against HIV-2 with EC50 of 3.5 μM. TMC125 also inhibits a series of HIV-1 group M subtypes and circulating recombinant forms and a group O virus.

In vivo

Etravirine has a high genetic barrier to the development of resistance. In phase IIb trials in treatment-experienced patients, including those infected with virus resistant to NNRTIs and protease inhibitors (PIs), TMC125 is active against HIV resistant to currently available NNRTIs, with a similar tolerability profile to that of the control group.


Synonyms

Benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-
4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile
TMC 125
Etravirine
R 165335
Intelence